Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Hatay
Clinical trial register · Turkey

Clinical Trials in Hatay, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5418 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5418
Studies in scope
all four open statuses
2461
Recruiting now
open to new participants
548
Lead sponsors
across recruiting studies
Top sites
Istanbul 1988 Ankara 1440 Izmir 568 Adana 377 Antalya 261
Narrow the registerReset
Recruitment status
Phase
Site location
Istanbul1988 Ankara1440 Izmir568 Adana377 Antalya261
All 318 locations
Target enrolment
to

Trials with a site in Hatay

23 of 5418 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Not yet open
Effect of Cyclic Sighing Breathing Exercise on CRBD, Pain, and Sleep Quality in Patients Undergoing TUR
NCT07843602Transurethral Resection of Bladder Tumor, Transurethral Resection of the Prostate (TURP), Transurethral Resection of the Bladder
Mersin University
Not applicable
76
Hatay
2026-10-01
Recruiting
Turkish Version of the BARSE
NCT07850661Healthy Adults, Exercise Self-Efficacy, Validation Studies
Mustafa Kemal University
Observational
130
Hatay
2026-10-01
Recruiting
Spinal Mobility, Rigidity, and Kinesiophobia in PD and TMD
NCT07850674PARKINSON DISEASE (Disorder), Rigidity, Temporomandibular Disorders (TMDs), Mobility
Mustafa Kemal University
Observational
60
Hatay
2026-09-23
Recruiting
Hacettepe University
Not applicable
30
Hatay
2026-09-01
Not yet open
Mustafa Kemal University
Observational
36
Antakya, Hatay
2026-07-04
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
Eli Lilly and Company
Phase 2
1,431
Adana, Ankara, Antalya, Bornova, Hatay, Istanbul, İzmit, Mersin
2026-03-26
Active, closed
Mustafa Kemal University
Not applicable
63
Hatay
2025-12-01
Recruiting
Outcomes of Pulpotomy and Root Canal Treatment in Teeth With Symptomatic Irreversible Pulpitis
NCT07375576Post-operative Pain, Pulpitis - Irreversible, Success Rate
Mustafa Kemal University
Not applicable
99
Hatay
2025-12-01
Recruiting
Eli Lilly and Company
Phase 2
252
Adana, Ankara, Antalya, Eskişehir, Hatay, İzmit, Malatya, Mersin
2025-11-10
Active, closed
Hacettepe University
Not applicable
60
Hatay
2025-10-08
Recruiting
The Effect of Different Intracanal Medicaments on Periapical Lesion Healing
NCT07237620Periapical Lesion Healing, Apical Periodontitis
Mustafa Kemal University
Not applicable
60
Hatay
2025-09-15
Not yet open
Effect of Mandala Practice on Menopausal Symptoms and Quality of Life
NCT07149285Menopause Symptom Management, Quality of Life, Menopausal Symptoms
Emine Karacan
Not applicable
78
Hatay
2025-09
Not yet open
Mustafa Kemal University
Not applicable
72
Hatay
2025-08-20
Recruiting
Eli Lilly and Company
Phase 3
290
Ankara, Bursa, Eskişehir, Hatay, Istanbul, Izmir, İzmit, Mersin
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
350
Ankara, Antalya, Bursa, Eskişehir, Hatay, Istanbul, Izmir, İzmit
2025-06-26
Recruiting
Body Awareness Therapy in High Stressed Young Adults: Effects on Function, Balance, Sleep and Mood
NCT07045792Stress, Psychological Factors, Sleep, Postural Balance
Mustafa Kemal University
Not applicable
30
Hatay
2025-05-30
Not yet open
Mustafa Kemal University
Observational
30
Hatay, Antakya
2025-02-20
Recruiting
Nadir Hastalıkları Araştırma Derneği
Observational
750
Adana, Batman, Diyarbakır, Elâzığ, Gaziantep, Hatay, Kahramanmaraş, Malatya
2023-09-06
Active, closed
Novo Nordisk A/S
Phase 3
3,400
Ankara, Sultangazi, Adana, Antalya, Hatay, Istanbul, Sivas
2022-11-01
Recruiting
Novartis Pharmaceuticals
Phase 4
130
Hatay, Adana
2021-06-10
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Ankara, Elâzığ, Hatay, Istanbul, Izmir
2018-04-13
Active, closed
AbbVie
Phase 3
747
Yenimahalle, Kadıköy, Şişli, Melikgazi, Ankara, Battalgazi/malatya, Hatay, Istanbul
2018-03-21
Rows per page Showing 1–23 of 23
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-turkey/city/hatay

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,418 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 23 of those studies with a site in Hatay.

How many clinical trials are recruiting in Hatay?

12 of the 23 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 5 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hatay), 23 studies
PhaseStudiesRecruitingShare
Not applicable10443.5%
Observational5321.7%
Phase 34217.4%
Phase 2228.7%
Phase 2/3104.3%
Phase 4114.3%

Most active sponsors

Lead sponsors with the most studies (Hatay)
Lead sponsorStudiesRecruiting
Mustafa Kemal University95
Eli Lilly and Company44
Hacettepe University21
AbbVie10
Arzu Çalışkan10
Emine Karacan10
Janssen Research & Development, LLC10
Mersin University10
Nadir Hastalıkları Araştırma Derneği11
Novartis Pharmaceuticals11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.